Skip to main content
argenx SE (ARGX)
NASDAQ: ARGX · Real-Time Price · USD
766.92
-4.61 (-0.60%)
At close: Feb 27, 2026, 4:00 PM EST
766.70
-0.22 (-0.03%)
After-hours: Feb 27, 2026, 7:39 PM EST

argenx SE Revenue

In the year 2025, argenx SE had annual revenue of $4.25B with 88.95% growth. argenx SE had revenue of $1.32B in the quarter ending December 31, 2025, with 74.57% growth.

Revenue (ttm)
$4.25B
Revenue Growth
+88.95%
P/S Ratio
11.19
Revenue / Employee
$2,656,692
Employees
1,599
Market Cap
47.54B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20254.25B2.00B88.95%
Dec 31, 20242.25B979.61M77.22%
Dec 31, 20231.27B827.58M187.66%
Dec 31, 2022441.01M-87.25M-16.52%
Dec 31, 2021528.27M466.31M752.59%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Regeneron Pharmaceuticals 14.34B
BeOne Medicines AG 5.34B
Incyte 5.14B
Genmab 3.72B
Alnylam Pharmaceuticals 3.71B
BioNTech SE 3.70B
Royalty Pharma 2.38B
Moderna 1.94B
Revenue Rankings

ARGX News

More News